Timentin and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is found among people who take Timentin, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Timentin and have Hyperkalemia. It is created by eHealthMe based on reports of 618 people who have side effects when taking Timentin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

618 people reported to have side effects when taking Timentin.
Among them, 16 people (2.59%) have Hyperkalemia.

What is Timentin?

Timentin has active ingredients of clavulanate potassium; ticarcillin disodium. eHealthMe is studying from 623 Timentin users for its effectiveness, alternative drugs and more.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 3,225 drugs and 2,827 conditions by eHealthMe.

Number of Timentin and Hyperkalemia reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Timentin and have Hyperkalemia?

Check whether Hyperkalemia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Hyperkalemia and when was it recovered:

Hyperkalemia in Timentin

Expand to all the drugs that have ingredients of clavulanate potassium; ticarcillin disodium:

Hyperkalemia and drugs with ingredients of clavulanate potassium; ticarcillin disodium

Alternative drugs to, pros and cons of Timentin:

Timentin (623 reports)

Hyperkalemia treatments and more:

Hyperkalemia (70,835 reports)

COVID vaccines that are related to Hyperkalemia:

Common drugs associated with Hyperkalemia:

All the drugs that are associated with Hyperkalemia:

Hyperkalemia (3,225 drugs)

Common conditions associated with Hyperkalemia:

High blood pressure: 9,321 reports
Type 2 diabetes: 2,927 reports
Diabetes: 2,483 reports
Pain: 1,908 reports
Atrial fibrillation/flutter: 1,835 reports

All the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,827 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clavulanate potassium; ticarcillin disodium (the active ingredients of Timentin) and Timentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.